olaquindox has been researched along with cyadox in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Graaf, GJ; Jager, LP; Nabuurs, MJ; van der Molen, EJ | 1 |
| Bakri, A; Beyersbergen van Henegouwen, GM; Bojarski, J; de Vries, H; Donker, AA | 1 |
| Baars, AJ; de Graaf, GJ; Jager, LP; van der Molen, EJ | 1 |
| Szabová, E | 1 |
| Cihák, R; Vontorková, M | 1 |
| Cihák, R; Srb, V | 1 |
| Fang, G; He, Q; Wang, D; Yuan, Z; Zhang, Y; Zhou, S | 1 |
| Ding, MX; Fan, SX; Wang, YL; Yuan, ZH; Zhu, HL | 1 |
| Ding, MX; Wang, YL; Yuan, ZH; Zhu, HL | 1 |
| Huang, LL; Huang, XJ; Liu, Y; Wang, X; Yan, CX; Yuan, ZH; Zhang, HH; Zhang, LY | 1 |
| He, QH; Huang, LL; Ihsan, A; Liu, ZL; Su, SJ; Wang, X; Wang, YL; Yuan, ZH; Zhou, W | 1 |
| Fang, GJ; Huang, LL; Ihsan, A; Liu, ZL; Wang, X; Wang, YL; Yuan, ZH; Zhou, W | 1 |
| Dai, M; Guo, W; Hao, H; Huang, L; Liu, Z; Peng, D; Sun, Y; Wang, H; Wang, X; Wang, Y; Yao, M; Yuan, Z | 1 |
| Liu, ZY; Sun, ZL | 1 |
| Cheng, G; Huang, L; Ihsan, A; Iqbal, Z; Liu, Z; Pan, Y; Tan, Z; Tu, H; Wang, X; Wang, Y; Yuan, Z; Zhang, W; Zhang, Y | 1 |
| Cheng, G; Dai, M; Hao, H; Li, B; Liang, G; Liu, Z; Wang, C; Wang, X; Wang, Y; Weng, Z; Yuan, Z; Zhang, H | 1 |
| Li, H; Miao, X; Xu, L; Yang, Z | 1 |
1 review(s) available for olaquindox and cyadox
| Article | Year |
|---|---|
The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview.
Topics: Animals; Carbadox; Humans; Quinoxalines | 2013 |
1 trial(s) available for olaquindox and cyadox
| Article | Year |
|---|---|
Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets.
Topics: Animals; Escherichia coli; Feces; Immunity, Mucosal; Immunologic Factors; Intestinal Mucosa; Male; Quinoxalines; Swine | 2006 |
15 other study(ies) available for olaquindox and cyadox
| Article | Year |
|---|---|
Clinical signs and performance of pigs treated with different doses of carbadox, cyadox and olaquindox.
Topics: Animals; Anti-Bacterial Agents; Carbadox; Female; Hematocrit; Male; Quinoxalines; Swine; Weight Gain | 1990 |
Photochemical reactions of quindoxin, olaquindox, carbadox and cyadox with protein, indicating photoallergic properties.
Topics: Animals; Anti-Bacterial Agents; Carbadox; Chemical Phenomena; Chemistry; Humans; Organophosphorus Compounds; Photochemistry; Photosensitivity Disorders; Proteins; Quinoxalines; Serum Albumin; Ultraviolet Rays | 1990 |
Comparative study of the effect of the effect of carbadox, olaquindox and cyadox on aldosterone, sodium and potassium plasma levels in weaned pigs.
Topics: Aldosterone; Animal Feed; Animals; Anti-Bacterial Agents; Carbadox; Female; Male; Potassium; Quinoxalines; Sodium; Swine | 1989 |
[Cytogenetic effects of non-antibiotic growth stimulators on bone marrow cells in mice].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carbadox; Chromosome Aberrations; Growth Substances; Male; Mice; Mice, Inbred ICR; Quinoxalines | 1988 |
Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. III. Transplacental micronucleus test in mice.
Topics: Administration, Oral; Animals; Bone Marrow; Carbadox; Cell Nucleus; Female; Fetus; Injections, Intraperitoneal; Liver; Maternal-Fetal Exchange; Mice; Mice, Inbred ICR; Pregnancy; Quinoxalines | 1985 |
Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. I. Micronucleus test in rats.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Carbadox; Cell Nucleus; Erythrocytes; Male; Mutagenicity Tests; Mutagens; Mutation; Quinoxalines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1983 |
Subchronic oral toxicity study with cyadox in Wistar rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Diet; Dose-Response Relationship, Drug; Epithelial Cells; Female; Hepatocytes; Kidney Tubules, Proximal; Male; No-Observed-Adverse-Effect Level; Quinoxalines; Rats; Rats, Wistar | 2006 |
Olaquindox and cyadox stimulate growth and decrease intestinal mucosal immunity of piglets orally inoculated with Escherichia coli.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Energy Intake; Escherichia coli; Immunoglobulin A; Intestinal Mucosa; Lymphocyte Count; Quinoxalines; Random Allocation; Swine; Weight Gain | 2006 |
ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro.
Topics: Adrenal Cortex; Animals; Apoptosis; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Mitochondria; Molecular Structure; Oxidation-Reduction; Quinoxalines; Reactive Oxygen Species; Swine; Time Factors | 2010 |
A chronic toxicity study of cyadox in Wistar rats.
Topics: Animals; Body Weight; Eating; Female; Kidney; Liver; Male; No-Observed-Adverse-Effect Level; Organ Size; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Toxicity Tests, Chronic; Transaminases | 2011 |
Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Analysis of Variance; Animal Feed; Animals; Animals, Newborn; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Epididymis; Female; Fetal Development; Male; Maternal Exposure; No-Observed-Adverse-Effect Level; Organ Size; Pregnancy; Quinoxalines; Rats; Rats, Wistar; Reproduction; Teratogens; Testis | 2011 |
Development of quinoxaline 1, 4-dioxides resistance in Escherichia coli and molecular change under resistance selection.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; DNA Primers; DNA, Complementary; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Glycolysis; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Nucleic Acid Hybridization; Oxides; Phenotype; Phosphorylation; Polymerase Chain Reaction; Quinoxalines; Swine | 2012 |
Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo.
Topics: Animals; Anti-Infective Agents; Bone Marrow Cells; Cell Line; Cells, Cultured; Cricetinae; Cricetulus; DNA Replication; Dose-Response Relationship, Drug; Humans; Lymphocytes; Male; Mice; Mice, Inbred Strains; Micronuclei, Chromosome-Defective; Mutagens; Mutation; Quinoxalines; Random Allocation; Salmonella typhimurium | 2013 |
Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Escherichia coli; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Annotation; Oxidation-Reduction; Oxidative Stress; Protein Biosynthesis; Proteomics; Quinoxalines; Reactive Oxygen Species; SOS Response, Genetics; Structure-Activity Relationship; Tirapazamine; Triazines | 2015 |
Determination of olaquindox, carbadox and cyadox in animal feeds by ultra-performance liquid chromatography tandem mass spectrometry.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Carbadox; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Quinoxalines; Solid Phase Extraction; Tandem Mass Spectrometry | 2018 |